Stoke Therapeutics
STOK
STOK
105 hedge funds and large institutions have $533M invested in Stoke Therapeutics in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
2.67% less ownership
Funds ownership: 109.91% → 107.24% (-2.7%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
94% less call options, than puts
Call options by funds: $308K | Put options by funds: $5.57M
Holders
105
Holding in Top 10
2
Calls
$308K
Puts
$5.57M
Top Buyers
| 1 | +$14.2M | |
| 2 | +$5.89M | |
| 3 | +$3.47M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.51M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.34M |
Top Sellers
| 1 | -$18.4M | |
| 2 | -$11.8M | |
| 3 | -$4.68M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$3.89M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.29M |